Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD)

NCT05657691 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

167

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder
MDD
Cognitive Impairment

Interventions

DRUG: Xanamem™
DRUG: Placebo

Sponsor

Actinogen Medical

Collaborators

[object Object]